TRiC/CCT can exert a beneficial effect on HD by preventing expanded polyQ aggregation and the resulting induced toxicity in neuronal cells, reinforcing autophagic clearance to restrict neuropathogenic protein aggregation, and increasing brain‐derived neurotrophic factor (BDNF) expression to ameliorate striatal atrophy. Here, BDNF is linked to Huntington disease.